Towards personalized cardiometabolic risk prediction: A fusion of exposome and AI

The influence of the exposome on major health conditions like cardiovascular disease (CVD) is widely recognized. However, integrating diverse exposome factors into predictive models for personalized health assessments remains a challenge due to the complexity and variability of environmental exposur...

Full description

Saved in:
Bibliographic Details
Main Authors: Zeinab Shahbazi, Slawomir Nowaczyk
Format: Article
Language:English
Published: Elsevier 2025-01-01
Series:Heliyon
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844024168909
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841526261639282688
author Zeinab Shahbazi
Slawomir Nowaczyk
author_facet Zeinab Shahbazi
Slawomir Nowaczyk
author_sort Zeinab Shahbazi
collection DOAJ
description The influence of the exposome on major health conditions like cardiovascular disease (CVD) is widely recognized. However, integrating diverse exposome factors into predictive models for personalized health assessments remains a challenge due to the complexity and variability of environmental exposures and lifestyle factors. A machine learning (ML) model designed for predicting CVD risk is introduced in this study, relying on easily accessible exposome factors. This approach is particularly novel as it prioritizes non-clinical, modifiable exposures, making it applicable for broad public health screening and personalized risk assessments. Assessments were conducted using both internal and external validation groups from a multi-center cohort, comprising 3,237 individuals diagnosed with CVD in South Korea within twelve years of their baseline visit, along with an equal number of participants without these conditions as a control group. Examination of 109 exposome variables from participants' baseline visits spanned physical measures, environmental factors, lifestyle choices, mental health events, and early-life factors. For risk prediction, the Random Forest classifier was employed, with performance compared to an integrative ML model using clinical and physical variables. Furthermore, data preprocessing involved normalization and handling of missing values to enhance model accuracy. The model's decision-making process were using an advanced explainability method. Results indicated comparable performance between the exposome-based ML model and the integrative model, achieving AUC of 0.82(+/-)0.01, 0.70(+/-)0.01, and 0.73(+/-)0.01. The study underscores the potential of leveraging exposome data for early intervention strategies. Additionally, exposome factors significant in identifying CVD risk were pinpointed, including daytime naps, completed full-time education, past tobacco smoking, frequency of tiredness/unenthusiasm, and current work status.
format Article
id doaj-art-3a680d6189034b97b998cd9868d41bca
institution Kabale University
issn 2405-8440
language English
publishDate 2025-01-01
publisher Elsevier
record_format Article
series Heliyon
spelling doaj-art-3a680d6189034b97b998cd9868d41bca2025-01-17T04:49:48ZengElsevierHeliyon2405-84402025-01-01111e40859Towards personalized cardiometabolic risk prediction: A fusion of exposome and AIZeinab Shahbazi0Slawomir Nowaczyk1Corresponding author.; Center for Applied Intelligent Systems Research, Halmstad University, SwedenCenter for Applied Intelligent Systems Research, Halmstad University, SwedenThe influence of the exposome on major health conditions like cardiovascular disease (CVD) is widely recognized. However, integrating diverse exposome factors into predictive models for personalized health assessments remains a challenge due to the complexity and variability of environmental exposures and lifestyle factors. A machine learning (ML) model designed for predicting CVD risk is introduced in this study, relying on easily accessible exposome factors. This approach is particularly novel as it prioritizes non-clinical, modifiable exposures, making it applicable for broad public health screening and personalized risk assessments. Assessments were conducted using both internal and external validation groups from a multi-center cohort, comprising 3,237 individuals diagnosed with CVD in South Korea within twelve years of their baseline visit, along with an equal number of participants without these conditions as a control group. Examination of 109 exposome variables from participants' baseline visits spanned physical measures, environmental factors, lifestyle choices, mental health events, and early-life factors. For risk prediction, the Random Forest classifier was employed, with performance compared to an integrative ML model using clinical and physical variables. Furthermore, data preprocessing involved normalization and handling of missing values to enhance model accuracy. The model's decision-making process were using an advanced explainability method. Results indicated comparable performance between the exposome-based ML model and the integrative model, achieving AUC of 0.82(+/-)0.01, 0.70(+/-)0.01, and 0.73(+/-)0.01. The study underscores the potential of leveraging exposome data for early intervention strategies. Additionally, exposome factors significant in identifying CVD risk were pinpointed, including daytime naps, completed full-time education, past tobacco smoking, frequency of tiredness/unenthusiasm, and current work status.http://www.sciencedirect.com/science/article/pii/S2405844024168909Cardiovascular diseaseExposomeClinical recordsArtificial intelligenceMachine learning
spellingShingle Zeinab Shahbazi
Slawomir Nowaczyk
Towards personalized cardiometabolic risk prediction: A fusion of exposome and AI
Heliyon
Cardiovascular disease
Exposome
Clinical records
Artificial intelligence
Machine learning
title Towards personalized cardiometabolic risk prediction: A fusion of exposome and AI
title_full Towards personalized cardiometabolic risk prediction: A fusion of exposome and AI
title_fullStr Towards personalized cardiometabolic risk prediction: A fusion of exposome and AI
title_full_unstemmed Towards personalized cardiometabolic risk prediction: A fusion of exposome and AI
title_short Towards personalized cardiometabolic risk prediction: A fusion of exposome and AI
title_sort towards personalized cardiometabolic risk prediction a fusion of exposome and ai
topic Cardiovascular disease
Exposome
Clinical records
Artificial intelligence
Machine learning
url http://www.sciencedirect.com/science/article/pii/S2405844024168909
work_keys_str_mv AT zeinabshahbazi towardspersonalizedcardiometabolicriskpredictionafusionofexposomeandai
AT slawomirnowaczyk towardspersonalizedcardiometabolicriskpredictionafusionofexposomeandai